Evidence map›Paper›PMID 37854973›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2023

Impact of previous coronary artery revascularization on outcomes in patients undergoing transcatheter aortic valve implantation.

Radosław Wilimski, Zenon Huczek, Kamil Krauz, Bartosz Rymuza, Maciej Mazurek, Piotr Scisło, Karol Zbroński, Kajetan Grodecki, Janusz Kochman, Mariusz Kuśmierczyk

Open access · goldAbstract read
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Transcatheter aortic valve implantation: latest evidence, gaps in knowledge, and future directions.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Radosław WilimskiDepartment of Cardio-Thoracic Surgery and Transplantology, Medical University of Warsaw, Warsaw, Poland.
Zenon Huczek1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Kamil KrauzDepartment of Cardio-Thoracic Surgery and Transplantology, Medical University of Warsaw, Warsaw, Poland.
Bartosz Rymuza1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Maciej Mazurek1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Piotr Scisło1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Karol Zbroński1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Kajetan Grodecki1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Janusz Kochman1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Mariusz KuśmierczykDepartment of Cardio-Thoracic Surgery and Transplantology, Medical University of Warsaw, Warsaw, Poland.
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) raises questions regarding the safety and efficacy of TAVI in this subset of patients. Aim: To evaluate the impact of previous coronary revascularization in terms of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) on clinical outcomes after TAVI. Material and methods: A total of 507 consecutive patients who underwent TAVI were divided into: non-revascularization (NR), post-PCI and post-CABG groups. The endpoints were established according to VARC-2 definitions. Results: Patients with previous coronary revascularization (36.7% of the population) were younger, more often male and their EuroSCORE II risk evaluation was significantly higher (NR 7.9% vs. post-PCI 8.0% vs. post-CABG 20.5%, Conclusions: TAVI seems to be a safe and effective procedure for the treatment of severe AS in patients with previous coronary revascularization.

Indexed as

coronary artery bypass graftingcoronary artery diseasepercutaneous coronary interventiontranscatheter aortic valve implantation

Identifiers

PMID37854973
PMCPMC10580857
OpenAlexW4387097425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.